Evidence map›Paper›PMID 41828439›Full record

ArticleInternational journal of molecular sciences2026

Glycated Albumin and Cardiovascular Mortality in CKD Stage V Patients with Diabetes Mellitus: A Five-Year Follow-Up Study.

Ana Bulatovic, Nada Dimkovic, Svetlana Jelic, Aleksandar Jankovic, Tatjana Damjanovic, Verica Todorov-Sakic, Jelena Bjedov, Bojan Stopic, Petar Djuric, Radomir Naumovic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana BulatovicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.
Nada DimkovicAcademy of Medical Sciences of the Serbian Medical Society, 11000 Belgrade, Serbia.
Svetlana JelicSchool of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Aleksandar JankovicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.ORCID 0000-0002-7931-973X
Tatjana DamjanovicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.
Verica Todorov-SakicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.ORCID 0009-0004-6096-5792
Jelena BjedovClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.
Bojan StopicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.ORCID 0000-0003-0827-9408
Petar DjuricClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.
Radomir NaumovicClinical Department for Nephrology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.ORCID 0000-0002-5520-2326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycemic assessment in patients with chronic kidney disease (CKD) Stage V on hemodialysis (HD) is limited by the inaccuracy of hemoglobin A1c (HbA1c), mainly due to anemia, shortened erythrocyte lifespan, and erythropoiesis-stimulating agent (ESA) therapy. Glycated albumin (GA), independent of erythrocyte turnover, may better reflect glycemic exposure. We evaluated the diagnostic performance and clinical utility of GA as a biomarker of poor glycemic control and cardiovascular risk in patients with diabetes mellitus (DM). A cross-sectional analysis and five-year prospective follow-up were conducted in three subgroups: HD+DM+ (

Indexed as

Cardiovascular DiseasesDiabetes MellitusRenal Insufficiency, ChronicSerum AlbuminAgedBiomarkersBlood GlucoseCross-Sectional StudiesFemaleFollow-Up StudiesGlycated HemoglobinGlycated Serum AlbuminGlycation End Products, AdvancedHumansMaleMiddle AgedBiomarkersBlood GlucoseGlycated HemoglobinGlycated Serum AlbuminGlycation End Products, AdvancedSerum Albumincardiovascular mortalityCKD Stage Vdiabetes mellitusglycated albuminglycemic markersHbA1chemodialysisvrh obrasca

Identifiers

PMID41828439
PMCPMC12984170

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.